Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/2/2006
 
First Published:
2/18/2005
1.
Phase II Trial of FavId™ (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI, Pharmaceutical / Industry
FAV-ID-09
CWRU-FVID-2404, CWRU-100415, NCT00104819, CASE-2404, FAV-WIRB-20041124
Last Modified:
3/11/2008
 
First Published:
11/18/2005
2.
Phase II Study of Immunotherapy Comprising Rituximab, Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine (FavId™), and Sargramostim (GM-CSF) in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
FAV-ID-70
FAV-ID-LYM-31, NCT00258336
Last Modified:
5/22/2008
 
First Published:
2/20/2008
3.
Phase II Study of Patient-Specific Immunotherapy Comprising Recombinant Tumor-Derived Immunoglobulin Idiotype-Keyhole Limpet Hemocyanin Conjugate Vaccine and Sargramostim (GM-CSF) in Patients With CNS Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
SCCC-102007-035
102007-035, SCCC-02F07, NCT00621036
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute